ANASTROZOLE 1 EURODRUG is indicated for the: Treatment of hormone receptor-positive advanced breast cancer in postmenopausal women; Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women; Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.